Cross Pharmaceuticals
Cross Pharmaceuticals is a privately held Greek pharmaceutical company founded in 1975, headquartered in Thessaloniki, that develops and distributes prescription medicines, OTC products, food supplements, medical devices, and dermocosmetics across dermatology, anti-infectives, blood disorders, and women's health for Greek pharmacies, physicians, and consumers.
- Company typePrivate
- Founded1975
- HeadquartersThérmi, Greece
- Headcount101–250
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Cross Pharmaceuticals does
Cross Pharmaceuticals is a privately held Greek pharmaceutical company founded in 1975 and headquartered in Thessaloniki, with a regional branch in Athens. The company operates a diversified healthcare portfolio spanning prescription medicines (Rx), over-the-counter (OTC) products, food supplements, medical devices, and dermocosmetics, with therapeutic focus on dermatology, anti-infectives, blood disorders, and women's health. Proprietary technology elements include the CEL BIOtechnology liposomal gel delivery platform and the GynoBiome vaginal microbiome restoration line, complemented by branded consumer franchises such as IZICOL, Izicol Junior, FertilU, Lactobiome, and Synergeia. The company holds ISO 9001 quality certification and operates under Greek National Organization for Medicines (EOF) regulatory oversight, with established pharmacovigilance practices.
The business operates through a hybrid B2B/B2C go-to-market model. B2B distribution flows through the Greek pharmacy network, a physician registration portal for accessing prescription product information and pricing, and direct supply to hospitals and rehabilitation centers. B2C channels include the company website (crosspharma.gr) with e-commerce functionality in Greek, English, and Spanish, alongside social media engagement. The website uses a login-based pricing model, consistent with registered-user B2B transactions rather than transparent consumer pricing.
Cross Pharmaceuticals self-identifies as one of the top five fastest-growing pharmaceutical companies in Greece and as having 50 years of pharmaceutical pioneering in the domestic market. Geographic operations remain concentrated in Greece with no disclosed export markets, though the multilingual website and CSR-driven institutional relationships suggest exploratory international and institutional positioning. No external funding rounds, parent company, or institutional investors are disclosed, indicating founder/management-controlled ownership under Greek private capital company (I.K.E.) structure.
Cross Pharmaceuticals firmographics
Firmographics- Name
- Cross Pharmaceuticals
- Legal name
- CROSS ΦΑΡΜΑΚΕΥΤΙΚΗ ΕΤΑΙΡΙΑ ΙΔΙΩΤΙΚΗ ΚΕΦΑΛΑΙΟΥΧΙΚΗ ΕΤΑΙΡΙΑ
- Website
- https://crosspharma.gr
- Company type
- Private
- Founded year
- 1975
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Cross Pharmaceuticals is a privately held Greek pharmaceutical company founded in 1975, headquartered in Thessaloniki, that develops and distributes prescription medicines, OTC products, food supplements, medical devices, and dermocosmetics across dermatology, anti-infectives, blood disorders, and women's health for Greek pharmacies, physicians, and consumers.
- Ownership category
- akta.pro rank
Cross Pharmaceuticals industry classification
Industry- Product category
- Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Dermatology Specialty Pharmaceuticals (HLAIACAL)
- akta.pro secondary industries
- Specialty Care Pharmaceuticals (HLAIAAAB), Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF), Probiotics & Digestive Health Supplements (CRADAGAF)
Keywords
Where Cross Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Thérmi
- HQ country
- Greece
- HQ region
- Europe
Offices2 records
Markets served
Cross Pharmaceuticals business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others
Revenue model
- Prescription Medicines (Rx): Prescription pharmaceutical products including anti-infectives, blood disease medications, and dermatological treatments sold through pharmacies and healthcare providers
- OTC and Non-Prescription Medicines: Non-prescription dermatological medicines, oral cavity treatments, and medical devices available for direct consumer purchase
- Pharmaceutical Products: Food supplements, medical technology products, and liposomal technology gels (CEL BIOtechnology) for consumer health and wellness
- Corporate Social Responsibility Donations: Donation of pharmaceutical and parapharmaceutical products to healthcare institutions as part of CSR initiatives
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
Cross Pharmaceuticals product offering
Product offeringCore offering
Cross Pharmaceuticals manufactures and distributes a diversified pharmaceutical portfolio in Greece, including prescription medicines (anti-infectives, blood disease and dermatological treatments), OTC/non-prescription medicines, food supplements, medical devices, and dermocosmetics under brands such as IZICOL, FertilU, GynoBiome, Lactobiome, Jomezal, CEL, and Synergeia. The company focuses on dermatology, anti-infectives, blood disorders, and women's health, utilizing proprietary CEL BIOtechnology liposomal gels for enhanced delivery of active ingredients.
Product overview
Cross Pharmaceuticals is a Greek pharmaceutical company with 50 years of experience, operating from 'Cure to Care' - expanding from pharmaceutical treatments to comprehensive healthcare. The company offers a diversified portfolio comprising prescription medicines (Rx) including corticosteroids for skin diseases (Momecort Cream), non-steroidal anti-inflammatory drugs (Jomezal), anti-infective medicines, and medicines for blood diseases. The non-prescription (OTC) portfolio includes dermatological medicines and medicines for oral cavity diseases. Para-pharmaceutical products include GynoBiome (vaginal microbiome restoration), FertilU (fertility support), Lactobiome (probiotics), and CEL BIOtechnology liposomal technology gels for advanced drug delivery. The company also markets brands including IZICOL, Izicol Junior, and Synergeia.
Differentiator
Problem solved
Functional benefit
Brands
- IZICOL: Brand of pharmaceutical products
- IZICOL Junior
- FertilU
- CEL
- GynoBiome
- Lactobiome
- Jomezal
- Synergeia
Products and services
- Momecort Cream Corticosteroid dermatological prescription medicine used for skin conditions, intended for prescribing physicians and patients with dermatological conditions.
- Jomezal Non-prescription non-steroidal anti-inflammatory drug used for conditions of the oral cavity and skin diseases, available for direct consumer purchase.
- GynoBiome Pharmaceutical product for vaginal microbiome restoration, addressing gynecological and women's health needs.
- FertilU Pharmaceutical product that improves conception conditions, supporting fertility and reproductive health for women seeking reproductive wellness.
- Lactobiome Probiotic pharmaceutical product within the Cross Pharmaceuticals portfolio, supporting microbiome health.
- CEL BIOtechnology Liposomal Gels Para-pharmaceutical liposomal technology gels for advanced delivery of active ingredients, utilizing CEL BIOtechnology as a differentiated delivery platform.
- Anti-infective Medicines Prescription medicines category covering anti-infective medications for the treatment of infections.
- Medicines for Blood Diseases Prescription medicines category covering treatments for hematological/blood disease conditions.
- Medicines for Skin Diseases Prescription medicines category covering dermatological treatments for skin diseases.
- Medical Technology Products Para-pharmaceutical category covering medical devices and medical technology products.
- Food Supplements Para-pharmaceutical nutritional and dietary supplements supporting consumer health and wellness.
Companies that use Cross Pharmaceuticals
Customer profileSegments5 records
Ideal customer profiles4 records
Cross Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Cross Pharmaceuticals partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights5 records
Cross Pharmaceuticals competitors and assessment
Company assessmentDirect peers
- Galenica: Greek pharmaceutical manufacturer producing generics, OTC products, and food supplements for the Greek market. Directly comparable in scale, product mix, and pharmacy distribution model.
- Help Pharmaceuticals: Greek pharmaceutical company offering Rx, OTC, food supplements, and dermocosmetics distributed through Greek pharmacies. Direct overlap with Cross in prescription dermatology and consumer health categories.
- Vianex: Greek pharmaceutical manufacturer with branded generics, OTC, and consumer health products across dermatology and specialty care. Comparable mid-cap size and Greek-domestic pharmacy distribution.
- ELPEN Pharmaceutical: Greek pharmaceutical manufacturer founded in Athens with a similar portfolio of branded generics, specialty pharma, and OTC products distributed through Greek pharmacies and hospitals. Closely comparable in scale, therapeutic focus, and Greek-domestic go-to-market.
- Uni-Pharma: Greek specialty pharmaceutical manufacturer focused on Rx generics across dermatology, CNS, and women's health. Comparable therapeutic categories and Greek-domestic B2B sales motion via pharmacies and hospitals.
- Demo S.A. One of the largest Greek pharmaceutical manufacturers, producing sterile injectables, generics, and specialty pharma with both Greek and export presence. Comparable product categories (injectable and topical Rx) and overlapping dermatology/women's health portfolios.
- Rafarm: Greek pharmaceutical company producing branded generics, specialty pharmaceuticals, and consumer health products for the domestic and select export markets. Comparable in mid-cap size, OTC/Rx mix, and Greek-domestic distribution model.
- Genesis Pharma: Greek specialty pharma company commercializing branded pharmaceuticals in therapeutic areas including dermatology, women's health, and specialty care. Closely aligned with Cross's therapeutic focus and physician-channel GTM.
Broad incumbents
- Lavipharm: Established Greek pharmaceutical and consumer healthcare company with a broader branded generics, OTC, and personal care portfolio. Comparable in dermocosmetics and OTC distribution but larger and more diversified.
- L'Oréal Dermatological Beauty: Global dermocosmetics leader (La Roche-Posay, Vichy, CeraVe) competing in the same medical-grade skincare and dermatology categories Cross addresses with its CEL BIOtechnology line. Represents the multinational competitive benchmark for Cross's dermocosmetic ambitions.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Cross Pharmaceuticals social profiles
Digital presenceCross Pharmaceuticals compliance and trust
Trust signalCompliance1 record
Cross Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cross Pharmaceuticals leadership team
Management profileNumber of profiles
Profiles1 record
Cross Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cross Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cross Pharmaceuticals
What does Cross Pharmaceuticals do?
Cross Pharmaceuticals manufactures and distributes a diversified pharmaceutical portfolio in Greece, including prescription medicines (anti-infectives, blood disease and dermatological treatments), OTC/non-prescription medicines, food supplements, medical devices, and dermocosmetics under brands such as IZICOL, FertilU, GynoBiome, Lactobiome, Jomezal, CEL, and Synergeia. The company focuses on dermatology, anti-infectives, blood disorders, and women's health, utilizing proprietary CEL BIOtechnology liposomal gels for enhanced delivery of active ingredients.
Is Cross Pharmaceuticals a public or private company?
Cross Pharmaceuticals is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Cross Pharmaceuticals founded?
Cross Pharmaceuticals was founded in 1975. It employs 101 to 250 people.
Where is Cross Pharmaceuticals based?
Cross Pharmaceuticals is headquartered in Thérmi, Greece, in the Europe region.
How does Cross Pharmaceuticals make money?
Four revenue lines are on record. Prescription Medicines (Rx) is the primary driver. The others are OTC and Non-Prescription Medicines, pharmaceutical Products and corporate Social Responsibility Donations.
Who are Cross Pharmaceuticals's main competitors?
Direct peers on record are Galenica, Help Pharmaceuticals, Vianex, ELPEN Pharmaceutical, Uni-Pharma, Demo S.A., Rafarm and Genesis Pharma. Broad incumbents are Lavipharm and L'Oréal Dermatological Beauty.
Does Cross Pharmaceuticals have an API?
No public API is recorded for Cross Pharmaceuticals.
What industry is Cross Pharmaceuticals in?
Cross Pharmaceuticals's product category is Pharmaceuticals. Its primary akta.pro industry code is HLAIACAL, Dermatology Specialty Pharmaceuticals, with a secondary code of HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.